Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2015 2
2017 1
2018 3
2019 3
2020 3
2021 6
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.
Núñez-Torrón Stock C, Jiménez Chillón C, Martín Moro F, Marquet Palomanes J, Velázquez Kennedy K, Piris Villaespesa M, Roldán Santiago E, Rodríguez Martín E, Chinea Rodríguez A, García Gutiérrez V, Moreno Jiménez G, López Jiménez J, Herrera Puente P. Núñez-Torrón Stock C, et al. Among authors: rodriguez martin e. Hematol Oncol. 2023 Oct;41(4):753-761. doi: 10.1002/hon.3160. Epub 2023 Apr 20. Hematol Oncol. 2023. PMID: 37081742
Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer.
Klett-Mingo JI, Pinto-Díez C, Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M, Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM, Martín ME. Klett-Mingo JI, et al. Among authors: rodriguez martin e. Cancers (Basel). 2022 Dec 30;15(1):227. doi: 10.3390/cancers15010227. Cancers (Basel). 2022. PMID: 36612223 Free PMC article.
The inhibition of NCS-1 binding to Ric8a rescues fragile X syndrome mice model phenotypes.
Cogram P, Fernández-Beltrán LC, Casarejos MJ, Sánchez-Yepes S, Rodríguez-Martín E, García-Rubia A, Sánchez-Barrena MJ, Gil C, Martínez A, Mansilla A. Cogram P, et al. Among authors: rodriguez martin e. Front Neurosci. 2022 Nov 16;16:1007531. doi: 10.3389/fnins.2022.1007531. eCollection 2022. Front Neurosci. 2022. PMID: 36466176 Free PMC article.
B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximab.
Chico-García JL, Rodríguez-Jorge F, Sainz-Amo R, Monreal E, Walo-Delgado P, Roldán E, Rodríguez-Martín E, Masjuan J, Costa-Frossard L, Sainz de la Maza S, Villar LM. Chico-García JL, et al. Among authors: rodriguez martin e. Mult Scler Relat Disord. 2022 Dec;68:104218. doi: 10.1016/j.msard.2022.104218. Epub 2022 Oct 8. Mult Scler Relat Disord. 2022. PMID: 36270253
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Fernández-Velasco JI, Monreal E, Kuhle J, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Oreja-Guevara C, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Lapuente-Suanzes P, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Diaz-Pérez C, Valero-López G, Diaz-Diaz J, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, García-Domínguez JM, Sabin J, Llufriu S, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: rodriguez martin e. Front Immunol. 2022 Mar 21;13:842354. doi: 10.3389/fimmu.2022.842354. eCollection 2022. Front Immunol. 2022. PMID: 35386690 Free PMC article.
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab.
Walo-Delgado PE, Monreal E, Medina S, Quintana E, Sainz de la Maza S, Fernández-Velasco JI, Lapuente P, Comabella M, Ramió-Torrentà L, Montalban X, Midaglia L, Villarrubia N, Carrasco-Sayalero A, Rodríguez-Martín E, Roldán E, Meca-Lallana J, Alvarez-Lafuente R, Masjuan J, Costa-Frossard L, Villar LM. Walo-Delgado PE, et al. Among authors: rodriguez martin e. Front Immunol. 2021 Oct 8;12:760546. doi: 10.3389/fimmu.2021.760546. eCollection 2021. Front Immunol. 2021. PMID: 34691084 Free PMC article. Clinical Trial.
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis.
Picón C, Tejeda-Velarde A, Fernández-Velasco JI, Comabella M, Álvarez-Lafuente R, Quintana E, Sainz de la Maza S, Monreal E, Villarrubia N, Álvarez-Cermeño JC, Domínguez-Mozo MI, Ramió-Torrentà L, Rodríguez-Martín E, Roldán E, Aladro Y, Medina S, Espiño M, Masjuan J, Matute-Blanch C, Muñoz-San Martín M, Espejo C, Guaza C, Muriel A, Costa-Frossard L, Villar LM. Picón C, et al. Among authors: rodriguez martin e. Front Immunol. 2021 Jul 12;12:685139. doi: 10.3389/fimmu.2021.685139. eCollection 2021. Front Immunol. 2021. PMID: 34322119 Free PMC article.
Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis.
Hernández-Breijo B, Plasencia-Rodríguez C, Navarro-Compán V, García-Hoz C, Nieto-Gañán I, Sobrino C, Bachiller-Corral J, Díaz-Almirón M, Martínez-Feito A, Jurado T, Lapuente-Suanzes P, Bonilla G, Pijoán-Moratalla C, Roy G, Vázquez-Díaz M, Balsa A, Villar LM, Pascual-Salcedo D, Rodríguez-Martín E. Hernández-Breijo B, et al. Among authors: rodriguez martin e. Front Med (Lausanne). 2021 Jun 17;8:683990. doi: 10.3389/fmed.2021.683990. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34222289 Free PMC article.
Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment.
Walo-Delgado PE, Sainz de la Maza S, Villarrubia N, Monreal E, Medina S, Espiño M, Fernández-Velasco JI, Rodríguez-Martín E, Roldán E, Lourido D, Muriel A, Masjuan-Vallejo J, Costa-Frossard L, Villar LM. Walo-Delgado PE, et al. Among authors: rodriguez martin e. Sci Rep. 2021 Apr 29;11(1):9299. doi: 10.1038/s41598-021-88624-7. Sci Rep. 2021. PMID: 33927255 Free PMC article.
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS.
Fernández-Velasco JI, Kuhle J, Monreal E, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Sánchez P, Carreón-Guarnizo E, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: rodriguez martin e. Neurol Neuroimmunol Neuroinflamm. 2021 Jan 6;8(2):e940. doi: 10.1212/NXI.0000000000000940. Print 2021 Mar 4. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33408167 Free PMC article.
23 results